Related content

Prognostic Value of Immunohistochemically Detected CD44 Isoforms CD44v5, CD44v7-8 in Human Breast Cancer

By Tempfer C.   Losch A.   Heinzl H.   Hausler G.   Hanzal E.   Kolbl H.   Breitenecker G.   Kainz C.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 2023-2025

Elsevier

Access to resources Recommend Favorite

CD44 variant expression and estrogen receptor status in breast cancer

By Hole A.K.   Belkhiri A.   S. Snell L.   Watson P.H.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 2, 1997-04 ,pp. : 165-173

Springer Publishing Company

Access to resources Recommend Favorite

Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer

By Vizoso Francisco   Fernández José   Corte María   Bongera Miguel   Gava Richard   Allende María   García-Muñiz José   García-Morán Manuel  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 11, 2004-11 ,pp. : 679-686

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Implications for Girdin Protein Expression in Breast Cancer

By Ling Yun   Jiang Ping   Cui Su-Ping   Ren Ya-Li   Zhu Sai-Nan   Yang Jing-Ping   Du Juan   Zhang Yan   Liu Jian-Ying   Zhang Bo  

Cancer Investigation, Vol. 29, Iss. 6, 2011-06 ,pp. : 405-410

Informa Healthcare

Access to resources Recommend Favorite

CD44⁺⁺/CD24⁻⁻ Cells Are Transit Progenitors and Do Not Determine the Molecular Subtypes and Clinical Parameters in Breast Carcinomas

By Lüü Xinquan   Xu Kejia   Lüü Huiyan   Yin Yuhui   Ma Changlu   Liu Yishan   Li Huixiang   Suo Zhenhe  

Ultrastructural Pathology, Vol. 35, Iss. 2, 2011-04 ,pp. : 72-78

Informa Healthcare

Access to resources Recommend Favorite